Dementia Scotland: Blood test could predict dementia up to 15 years before diagnosis, study shows scotsman.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scotsman.com Daily Mail and Mail on Sunday newspapers.
Combination treatment with cabozantinib and atezolizumab did not produce any new safety signals in the treatment of those with metastatic castration-resistant prostate cancer in the phase 3 CONTACT-02 trial.
Paris , 29 May 2018 - Ipsen today announced that cabozantinib and irinotecan liposome injection are the subject of 8 presentations at the 2018 American Society of Clinical.
Bradley A. McGregor, MD, discusses the clinical significance of the updated COSMIC-021 data, how these findings support the continued investigation of IO/TKI combinations in non–clear cell renal cell carcinoma, and other efforts underway to better care for patients with varying histological subtypes of the disease.
MarkNtel Advisors has released a brand-new research study with a thorough analysis of the Hepatocellular Carcinoma (HCC) Market. Stakeholders can profit